|
Double Counting in Meta-Analysis
|
|
3
|
174
|
April 10, 2024
|
|
Hybrid AI & Delphi Based Derivation of RCT and Bedside Measurements
|
|
10
|
499
|
April 10, 2024
|
|
Sample size calculation for metabolomic profiles in a nested case-control study
|
|
0
|
153
|
April 8, 2024
|
|
Use of percentage change in clinical trials
|
|
16
|
657
|
April 8, 2024
|
|
When is it clinically reasonable to assume transportability of RCT effects?
|
|
7
|
249
|
April 7, 2024
|
|
Immortal-time-bias vs. selection bias
|
|
2
|
211
|
April 7, 2024
|
|
RMS Describing, Resampling, Validating, and Simplifying the Model
|
|
158
|
39720
|
April 4, 2024
|
|
Run-in phase in RCTs
|
|
14
|
9654
|
April 1, 2024
|
|
Relationship between Probabilistic Index and Common Odds Ratio
|
|
1
|
128
|
April 1, 2024
|
|
RMS Titanic Binary Logistic Case Study
|
|
9
|
13714
|
March 28, 2024
|
|
External validation of a time-to-event prognostic model
|
|
1
|
226
|
March 26, 2024
|
|
Numerical Differences in Survival Probability Estimates between coxph and cph Functions
|
|
8
|
627
|
March 24, 2024
|
|
Individual response
|
|
236
|
34576
|
March 24, 2024
|
|
Redundancy analysis of covariates in a Cox model using flexible parametric additive models
|
|
9
|
528
|
March 22, 2024
|
|
Progression in cancer trials
|
|
25
|
3390
|
March 22, 2024
|
|
Validate and calibrate Cox model on dataset with a categorical covariate with few observations
|
|
2
|
224
|
March 21, 2024
|
|
Calculate incidence rate after adjustment
|
|
10
|
1303
|
March 19, 2024
|
|
Choosing variables for mutivariable survival prediction
|
|
21
|
3719
|
March 18, 2024
|
|
Executable Specification of Dose Escalation Oncology Protocol now on Arxiv
|
|
2
|
201
|
March 16, 2024
|
|
Bayesian vs. Frequentist Statements About Treatment Efficacy
|
|
0
|
1350
|
September 4, 2022
|
|
Model Performance with Repeat Predictions
|
|
10
|
282
|
March 12, 2024
|
|
External Validation and Calibration of Cox model
|
|
13
|
5136
|
March 12, 2024
|
|
Communicating statistical concerns to the FDA
|
|
3
|
381
|
March 11, 2024
|
|
Retrospective discussion on the ALS drug, RELYVRIO
|
|
0
|
259
|
March 10, 2024
|
|
Tresholds in bayesian designs
|
|
0
|
124
|
March 6, 2024
|
|
Random effects in mixed-effect multivariable logistic regression models
|
|
0
|
221
|
March 5, 2024
|
|
RMS Ordinal Logistic Regression
|
|
34
|
13962
|
March 3, 2024
|
|
Statistical Parameter Mapping
|
|
4
|
265
|
February 28, 2024
|
|
Percentage as a measure of a predictor variable
|
|
7
|
436
|
February 27, 2024
|
|
Is Lithium Equivalent to Lecanemab in Slowing cognitive decline in Alzheimer's Disease?
|
|
0
|
356
|
February 23, 2024
|